PADI4 and rheumatoid arthritis: The citrullinating enzyme peptidylarginine deiminase 4 (PADI4) was identified as a susceptibility gene in a case–control study by Suzuki et al., using single nucleotide polymorphisms (SNPs) and also examining serum from individuals suffering from RA [26].